Advanced search
Publication Cover
Leukemia & Lymphoma Volume 65, 2024 - Issue 5
Submit an article Journal homepage
400
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement

Anath C. Lionela Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Ashwath Gurumurthia Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Ahmed Fetooha Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Rami Eldayab Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sairah Ahmeda Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Swaminathan P. Iyera Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Loretta J. Nastoupila Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Jason Westina Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Ranjit Naira Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Luis Fayada Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Luis Malpicaa Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sudhakar Tummalac Department of Neuro-oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Christopher Flowersa Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sattva S. Neelapua Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Michael L. Wanga Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Preetesh Jaina Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2735-168XView further author information
ORCID Icon show all
Pages 669-673 | Received 27 Nov 2023, Accepted 08 Jan 2024, Published online: 22 Jan 2024

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.